Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02647021
What this trial is testing

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors

Who this might be right for
Head and Neck NeoplasmsAccessory Nerve InjuryFatigue
University of Alberta 60
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Early research (Phase 1)Ended earlyNCT03596658
What this trial is testing

SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer

Who this might be right for
ER+ HER2- Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT04447755
What this trial is testing

Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Who this might be right for
Relapsed or Refractory Solid Tumors
Merck Sharp & Dohme LLC 127
Not applicableStudy completedNCT05704855
What this trial is testing

A Combined Exercise Training Program for Women Living With Breast Cancer

Who this might be right for
Breast Cancer
University of Toronto 21
Testing effectiveness (Phase 2)Looking for participantsNCT07087158
What this trial is testing

IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Imbioray (Hangzhou) Biomedicine Co., Ltd. 30
Not applicableLooking for participantsNCT06049420
What this trial is testing

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Who this might be right for
ObesityHyperlipidemiasPolycystic Ovary Syndrome+6 more
West Virginia School of Osteopathic Medicine 95
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02212197
What this trial is testing

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

Who this might be right for
Prostate Cancer
Camurus AB 51
Not applicableLooking for participantsNCT07556380
What this trial is testing

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Who this might be right for
Melanoma (Skin Cancer)
Northwestern University 150
Early research (Phase 1)Study completedNCT02006979
What this trial is testing

Acute Exercise Cardioprotection From Doxorubicin

Who this might be right for
Breast Cancer
University of British Columbia 27
Early research (Phase 1)Study completedNCT07040943
What this trial is testing

Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.

Who this might be right for
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
West China Hospital 6
Early research (Phase 1)Looking for participantsNCT07281326
What this trial is testing

AK138D1 in Advanced Malignant Tumors

Who this might be right for
Solid Cancer
Akeso 200
Testing effectiveness (Phase 2)Looking for participantsNCT04106115
What this trial is testing

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

Who this might be right for
Bladder Cancer
University College, London 52
Early research (Phase 1)UnknownNCT00641160
What this trial is testing

Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies

Who this might be right for
Nonhematologic Malignancies
Metronome Therapeutics 12
Not applicableStudy completedNCT05216380
What this trial is testing

Study of Clinic-delivered Physical Activity Referrals to Cancer Survivors

Who this might be right for
CancerPhysical Inactivity
University of Massachusetts, Worcester 69
Testing effectiveness (Phase 2)Ended earlyNCT04808362
What this trial is testing

Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours

Who this might be right for
Advanced Solid TumorsPancreatic CancerCRC
Peptomyc S.L. 22
Early research (Phase 1)Looking for participantsNCT07510308
What this trial is testing

Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients

Who this might be right for
pMMR/MSS Advanced Colorectal Cancer
West China Hospital 9
Not applicableStudy completedNCT02963740
What this trial is testing

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Who this might be right for
Breast Cancer Female
University of Kansas Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT01959282
What this trial is testing

Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 219
Next Page